(Q36871507)

16 August 2017

1 reference

title

Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer (English)

1 reference

16 August 2017

0 references

Gina Brown

2

0 references

David Cunningham

object named as

David Cunningham

4

0 references

author name string

Brian D P O'Neill

1

1 reference

16 August 2017

R J Heald

3

1 reference

16 August 2017

Diana M Tait

5

1 reference

16 August 2017

publication date

1 July 2007

1 reference

Lancet Oncology Commission

16 August 2017

published in

1 reference

16 August 2017

volume

8

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

625-633

1 reference

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Pathological features of rectal cancer after preoperative radiochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Rectal cancer: the influence of tumor proliferation on response to preoperative irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Endocavitary radiation therapy for rectal adenocarcinoma: 10-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Combined curative radiation therapy alone in (T1) T2-3 rectal adenocarcinoma: a pilot study of 29 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Present status of radiation therapy in the conservative management of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Role of pre-operative irradiation for anal preservation in cancer of the low rectum

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

No downstaging after short-term preoperative radiotherapy in rectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Prognostic value ofP53mutations in rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Molecular prognostic factors in rectal cancer treated by radiation and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970202-4

7 January 2021

10.1016/S1470-2045(07)70202-4

Identifiers

DOI

1 reference

16 August 2017

1 reference